I have no problems with this issue. I recall there was a placement similar to this before they announced the striate partnership with biohorizons. We know we are on the cusp of deals with remplir and ati over the next couple of years. Negotiations must be in full swing behind the scenes. My thinking is ATI will be sold on, hopefully retaing some sort of ongoing royalties. But i think there will be a deal to supply remplir into the U.S. market.
Ann: Proposed issue of securities - OCC, page-17
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.005(1.37%) |
Mkt cap ! $77.54M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 37.0¢ | $4.309K | 11.64K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2629 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 9866 | 1 |
View Market Depth
| Last trade - 15.34pm 19/08/2024 (20 minute delay) ? |
| OCC (ASX) Chart |